<DOC>
	<DOCNO>NCT01569113</DOCNO>
	<brief_summary>The purpose study compare effect ovarian activity quick start Combined Oral Contraceptive Pill ( COCP ) ellaOne® placebo intake .</brief_summary>
	<brief_title>Assessment Effects Ovarian Activity Combined Oral Contraceptive Pill When Preceded Intake ellaOne® Placebo .</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Ethinyl Estradiol-Norgestrel Combination</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Healthy woman age 1835 year old BMI &lt; 30 Kg/m2 Not risk pregnancy No use progesteroneonlypill 3 month start treatment cycle No use implant hormonal contraception 3 month start treatment cycle No use levonorgestrel intrauterine system 3 month start treatment cycle No use depo provera 12 month start treatment cycle Able give inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>ella</keyword>
	<keyword>ellaOne</keyword>
	<keyword>quickstart</keyword>
	<keyword>contraception</keyword>
	<keyword>combine oral pill</keyword>
	<keyword>microgynon</keyword>
</DOC>